New funding is empowering our clinicians and scientists to combine genomic, molecular and neuroimaging expertise at a heightened level to refine the individualization of epilepsy care.
Child neurologists are starting to recommend epilepsy surgery sooner rather than later for their patients with uncontrolled seizures. Here’s why, along with tips for reassuring reluctant parents.
World experts on FCD are updating the classification of this group of drug-resistant focal epilepsies. This comprehensive CME summit will give a preview of the changes and the evidence behind them.
From increased risks to effective screening approaches, special pediatric considerations and the role of medications, our expert shares insights on the intersection of seizures and suicidality.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Median seizure reduction was substantially greater after nine years of therapy than after three years, reveals a long-term prospective study of the implantable RNS neuromodulation system.
The shared grant to Cleveland Clinic and Case Western Reserve University will support application of computer post-processing to MR fingerprinting images to pinpoint seizure origins in challenging cases.
Ongoing research is pursuing glucocorticoid receptors as a potential therapeutic target to overcome the role of blood-brain barrier dysfunction in pharmacoresistant epilepsy.
As use of continuous EEG monitoring during hospitalization grows, more patients with no epilepsy history are being discharged on antiepileptic drugs. Here’s why and how we’re monitoring them in a new clinic.
New patient series show that MR fingerprinting contributes to epileptic lesion characterization beyond conventional MRI and that computer-assisted MRI post-processing enhances detection of subtle abnormalities in challenging cingulate and orbitofrontal epilepsies.
The new deep brain stimulation system for epilepsy seems best suited to patients whose seizures are hard to localize or restrict to just a couple brain regions. We share insights as one of the initial U.S. treating sites.